Who
Subhashis Banerjee
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Artiva Biotherapeutics.
In numbers
- Trades disclosed
- 25
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $367K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 8 Apr 2025
- Last trade
- 5 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 6 Oct 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $7,5141,099 at $6.84 | filing |
| 9 Sep 2026filed 11 Sep 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 3 Sep 2026filed 4 Sep 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $12K1,100 at $11.16 | filing |
| 3 Sep 2026filed 4 Sep 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $12K1,100 at $11.16 | filing |
| 27 Aug 2026filed 31 Aug 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Code M | $10K5,306 at $1.92 | filing |
| 27 Aug 2026filed 31 Aug 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $99K8,222 at $12.01 | filing |
| 27 Aug 2026filed 31 Aug 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,306 at $0.00 | filing |
| 27 Aug 2026filed 31 Aug 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,306 at $0.00 | filing |
| 27 Aug 2026filed 31 Aug 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Code M | $10K5,306 at $1.92 | filing |
| 27 Aug 2026filed 31 Aug 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $99K8,222 at $12.01 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Code M | $824429 at $1.92 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $5,148429 at $12.00 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —429 at $0.00 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —429 at $0.00 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Code M | $824429 at $1.92 | filing |
| 18 Aug 2026filed 19 Aug 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $5,148429 at $12.00 | filing |
| 19 May 2026filed 19 May 2026 | ARTV Artiva BiotherapeuticsBiotechnology | SEC FORM 4 Sold | $63K7,037 at $9.01 | filing |
News
No headline names them, or the companies they trade most, lately.